The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Validation of in-vitro bioassay methods: Application in herbal drug research
Abstract
This present review described the validation method of in-vitro bioassay for its application in herbal drug research. Seven sequencing steps that can be taken for performing a valid bioassay include: literature survey, sample stability evaluation, Biosystem performance testing, Sample performance evaluation, determination of 50% effective concentration or cytotoxic concentrations, selective index evaluation, and determination of accurate relative potency of sample. Detailed methods and acceptance criteria for each step are described herein. Method calculations of the relative potency of sample using European Pharmacopeia 10.0, 5.3 (2020) were recommended instead of using United States Pharmacopeia 42 (2019). For having reliable data and conclusions, all methods (chemical and bioassay) need to be first validated before any data collection. Absence of any validation method may results in incorrect conclusions and bias.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhang, J.-H., Chung, T. D. Y., & Oldenburg, K. R. (1999) · SLAS Discovery · doi:10.1177/108705719900400206 · Cited by 6,847
Performance standards for antimicrobial susceptibility testing
Weinstein, M. P., & Clinical (2019) · Clinical and Laboratory Standards Institute eBooks · Cited by 4,341
Anti-infective potential of natural products: How to develop a stronger in vitro ‘proof-of-concept’
Cos, P., Vlietinck, A. J., Berghe, D. V., & Maes, L. (2006) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2006.04.003 · Cited by 1,603
Gene-Wide Analysis Detects Two New Susceptibility Genes for Alzheimer's Disease
Escott-Price, V., Bellenguez, C., Wang, L.-S., Choi, S.-H., Harold, D., Jones, L., Holmans, P., Gerrish, A., Vedernikov, A., Richards, A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094661 · Cited by 1,398
Guidelines for accurate EC50/IC50 estimation
Sebaugh, J. L. (2011) · Pharmaceutical Statistics · doi:10.1002/pst.426 · Cited by 946
Pan, S.-Y., Zhou, S.-F., Gao, S.-H., Yu, Z.-L., Zhang, S.-F., Tang, M.-K., Sun, J.-N., Ma, D.-L., Han, Y.-F., Fong, W.-F., et al. (2013) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2013/627375 · Cited by 687
Riss, T., Moravec, R. A., Niles, A. L., Duellman, S. J., Benink, H. A., Worzella, T. J., & Minor, L. K. (2016) · Europe PMC (PubMed Central) · Cited by 469
EC50 estimation of antioxidant activity in DPPH assay using several statistical programs
Chen, Z., Bertin, R., & Froldi, G. (2013) · Food Chemistry · doi:10.1016/j.foodchem.2012.11.001 · Cited by 466
General Cytotoxicity Assessment by Means of the MTT Assay
Tolosa, L., Donato, M. T., & Gómez-Lechón, M. J. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-2074-7_26 · Cited by 390
Batista, R., De Jesus Silva Júnior, A., & De Oliveira, A. B. (2009) · Molecules · doi:10.3390/molecules14083037 · Cited by 304
Peña-Morán, O., Villarreal, M., Álvarez-Berber, L., Meneses-Acosta, A., & Rodríguez-López, V. (2016) · Molecules · doi:10.3390/molecules21081013 · Cited by 241
Iversen, P. W., Eastwood, B. J., Sittampalam, G. S., & Cox, K. L. (2006) · SLAS Discovery · doi:10.1177/1087057105285610 · Cited by 237
Famuyide, I. M., Aro, A. O., Fasina, F. O., Eloff, J. N., & McGaw, L. J. (2019) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-019-2547-z · Cited by 229
Analytical Techniques for Metabolomic Studies: A Review
Segers, K., Declerck, S., Mangelings, D., Heyden, Y. V., & Eeckhaut, A. V. (2019) · Bioanalysis · doi:10.4155/bio-2019-0014 · Cited by 225
Nutraceuticals : Efficacy, Safety and Toxicity
Gupta, R. C. (2016) · Cited by 221
Evaluation of the anticancer potential of six herbs against a hepatoma cell line
Weerapreeyakul, N., Nonpunya, A., Barusrux, S., Thitimetharoch, T., & Sripanidkulchai, B. (2012) · Chinese Medicine · doi:10.1186/1749-8546-7-15 · Cited by 177
Standards for cell line authentication and beyond
Almeida, J. L., Cole, K. D., & Plant, A. L. (2016) · PLoS Biology · doi:10.1371/journal.pbio.1002476 · Cited by 154
Screening of medicinal plants from Reunion Island for antimalarial and cytotoxic activity
Jonville, M., Kodja, H., Humeau, L., Fournel, J., Mol, P. D., Cao, M. H. T., Angenot, L. J. G., & Frédérich, M. (2008) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2008.09.005 · Cited by 151
Awouafack, M. D., McGaw, L. J., Gottfried, S., Mbouangouere, R., Tane, P., Spiteller, M., & Eloff, J. N. (2013) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-13-289 · Cited by 148
Kellogg, J. J., Paine, M. F., McCune, J. S., Oberlies, N. H., & Cech, N. B. (2019) · Natural Product Reports · doi:10.1039/c8np00065d · Cited by 128
Models and Methods for In Vitro Toxicity
Jain, A. K., Singh, D. K., Dubey, K., Maurya, R., Mittal, S., & Pandey, A. K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804667-8.00003-1 · Cited by 113
Validation of alternative methods for toxicity testing
Bruner, L. H., Carr, G. J., Chamberlain, M. P., et al. (1996) · Toxicology in Vitro · doi:10.1016/0887-2333(96)00028-8 · Cited by 110
(2018) · Elsevier eBooks · doi:10.1016/c2016-0-01687-x · Cited by 89
Antiviral and Antioxidant Properties of Echinochrome A
Fedoreyev, S. A., Nv, K., Mishchenko, N. P., Васильева, Е. А., Pislyagin, Е. А., Iunikhina, O. V., Lavrov, V. F., Свитич, О. А., Ebralidze, L. K., & Leonova, G. N. (2018) · Marine Drugs · doi:10.3390/md16120509 · Cited by 86
Cell-line authentication demystified
Marx, V. (2014) · Nature Methods · doi:10.1038/nmeth.2932 · Cited by 80
Prasetyaningrum, P. W., Bahtiar, A., & Hayun, H. (2018) · Scientia Pharmaceutica · doi:10.3390/scipharm86020025 · Cited by 77
Martin, H. L., Adams, M., Higgins, J. W., Bond, J., Morrison, E. E., Bell, S. M., Warriner, S. L., Nelson, A. S., & Tomlinson, D. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088338 · Cited by 76
Bagla, V. P., McGaw, L. J., Elgorashi, E. E., & Eloff, J. N. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-383 · Cited by 73
López‐Lázaro, M. (2015) · Oncoscience · doi:10.18632/oncoscience.132 · Cited by 69
Validation of Chromatographic Methods of Analysis: Application for Drugs That Derived From Herbs
Indrayanto, G. (2018) · Profiles of drug substances, excipients, and related methodology · doi:10.1016/bs.podrm.2018.01.003 · Cited by 61
Recent Development of Quality Control Methods for Herbal Derived Drug Preparations
Indrayanto, G. (2018) · Natural Product Communications · doi:10.1177/1934578x1801301208 · Cited by 59
Pritchett, J. C., Naesens, L., & Montoya, J. (2014) · Human Herpesviruses HHV-6A, HHV-6B & HHV-7 · doi:10.1016/b978-0-444-62703-2.00019-7 · Cited by 58
Ory, L., Nazih, H., Daoud, S., Mocquard, J., Bourjot, M., Margueritte, L., Delsuc, M., Bard, J., Pouchus, Y. F., Bertrand, S., et al. (2019) · Analytica Chimica Acta · doi:10.1016/j.aca.2019.04.038 · Cited by 57
Assay Guidance Manual : Quantitative Biology and Pharmacology in Preclinical Drug Discovery
Coussens, N. P., Sittampalam, G. S., Guha, R., Brimacombe, K. R., Grossman, A., Chung, T. D. Y., Weidner, J. R., Riss, T., Trask, O. J., Auld, D. S., et al. (2018) · Clinical and Translational Science · doi:10.1111/cts.12570 · Cited by 52
Repositioning approved drugs for the treatment of problematic cancers using a screening approach
Varbanov, H. P., Kuttler, F., Banfi, D., Turcatti, G., & Dyson, P. J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171052 · Cited by 49
Advanced Assay Development Guidelines for Image-Based High Content Screening and Analysis
Bray, M., & Carpenter, A. E. (2012) · Cited by 44
How many times should we screen a chemical library to discover an anticancer drug?
López‐Lázaro, M. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.12.006 · Cited by 43
In Silico Approaches for Predictive Toxicology
Parthasarathi, R., & Dhawan, A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804667-8.00005-5 · Cited by 42
The History of Alternative Test Methods in Toxicology
(2018) · Elsevier eBooks · doi:10.1016/c2016-0-00193-6 · Cited by 42
In vitro anti-trypanosomal effects of selected phenolic acids on Trypanosoma brucei
Amisigo, C. M., Antwi, C. A., Adjimani, J. P., & Gwira, T. M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216078 · Cited by 36
Anti-malarial effect of novel chloroquine derivatives as agents for the treatment of malaria
Yeo, S., Liu, D., Kim, H. S., & Park, H. (2017) · Malaria Journal · doi:10.1186/s12936-017-1725-z · Cited by 34
Development of In Vitro Toxicology
Singh, S., Khanna, V. K., & Pant, A. B. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804667-8.00001-8 · Cited by 17
Principles for In Vitro Toxicology
Srivastava, S., Mishra, S., Dewangan, J., Divakar, A., Pandey, P. K., & Rath, S. K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804667-8.00002-x · Cited by 16
Saesong, T., Allard, P., Queiroz, E. F., Marcourt, L., Nuengchamnong, N., Temkitthawon, P., Khorana, N., Wolfender, J., & Ingkaninan, K. (2019) · Molecules · doi:10.3390/molecules24162989 · Cited by 16
Minimum Significant Ratio – A Statistic to Assess Assay Variability
Haas, J. V., Eastwood, B. J., Iversen, P. W., Devanarayan, V., & Weidner, J. R. (2013) · Europe PMC (PubMed Central) · Cited by 14
Alternative Approaches for Carcinogenicity and Reproductive Toxicity
Corvi, R., Spielmann, H., & Härtung, T. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813697-3.00024-x · Cited by 12
Alternative In Vitro Models for Safety and Toxicity Evaluation of Nutraceuticals
Krishna, G., & Gopalakrishnan, G. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802147-7.00027-9 · Cited by 11
The Importance of Cell Line Authentication
(2013) · BioTechniques · doi:10.2144/000114014 · Cited by 1
Cited by
Samakkarnthai, P., Saul, D., Zhang, L., Aversa, Z., Doolittle, M. L., Sfeir, J. G., Kaur, J., Atkinson, E. J., Edwards, J. R., Russell, G. G., et al. (2023) · Aging · doi:10.18632/aging.204701 · Cited by 34
(2022) · PubMed Central · Cited by 17
Metadata
- Venue
- Profiles of Drug Substances, Excipients and Related Methodology
- Publisher
- Elsevier
- Published
- 2021
- Volume
- 46
- Pages
- 273-307
- ISSN
- 1871-5125 (ISSN-L)
- OpenAlex
- W3081667723
- Cited by
- 482
- References
- 48
- FWCI
- 102.84
- Type
- book chapter
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.